Scleroderma, Systemic - 20 Studies Found
Recruiting |
: Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis : Scleroderma, Systemic : 2015-08-31 :
|
Not yet recruiting |
: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study : Scleroderma, Systemic : 2017-03-23 :
|
Completed |
: Efficacy and Safety of Imatinib in Scleroderma :
|
Completed |
: Oral Manifestations of Systemic Sclerosis : Scleroderma, Systemic : 2015-02-18 : Radiation: Cone Beam Computed Tomography (CBCT) |
Recruiting |
: Scleroderma Registry & Repository at the Hospital for Special Surgery : Scleroderma : 2012-08-01 |
Completed |
: Nilotinib in the Treatment of Systemic Sclerosis : Systemic Sclerosis : 2010-07-01 : Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Active, not recruiting |
: Taking Charge of Systemic Sclerosis : Scleroderma : 2015-05-22 :
|
Completed |
: Morbidity and Mortality Follow Up for the Scleroderma Lung Study : Scleroderma : 2013-01-04 : Other: Followup survey |
Completed |
: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis : Systemic Sclerosis : 2007-11-07 : Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis : Systemic Sclerosis : 2008-04-25 |